OM
ABEO icon

Opaleye Management’s Abeona Therapeutics ABEO Stock Holding History

Opaleye Management’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-22,400
Closed -$4.12M – 44
2019
Q1 		$4.12M Buy
22,400
+4,400
+24% +$787K 1.14% 34
2018
Q4 		$3.21M Buy
+18,000
New +$3.93M 1.2% 25
2017
Q2 		– Sell
-11,000
Closed -$1.38M – 42
2017
Q1 		$1.38M Sell
11,000
-5,000
-31% -$645K 0.68% 35
2016
Q4 		$1.94M Buy
16,000
+12,000
+300% +$1.88M 1.14% 26
2016
Q3 		$600K Buy
+4,000
New +$391K 0.31% 41

Other funds holding ABEO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Opaleye Management's ABEO Position: Q2 2019 in Review

Opaleye Management sold out of Abeona Therapeutics (ABEO) in Q2 2019, closing a stake of 22,400 shares — an estimated $4.12M sold.

Opaleye Management first reported a position in ABEO in Q3 2016 and held it in 5 quarters. The position peaked at $4.12M in Q1 2019. 98 funds tracked by Wall St. Rank hold ABEO as of Q2 2019.

  • Opaleye Management reported no remaining Abeona Therapeutics position as of Q2 2019 after selling out during the quarter.
  • Opaleye Management sold 22,400 Abeona Therapeutics shares in Q2 2019, an estimated $4.12M.
  • Opaleye Management first reported a position in Abeona Therapeutics in Q3 2016 and held it in 5 quarters.
  • Opaleye Management's Abeona Therapeutics position peaked at $4.12M in Q1 2019.
  • 98 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2019.

Based on Opaleye Management's 13F filing for Q2 2019, filed 14 Aug 2019.